- Home
- PFBC vs TOVX Comparison
PFBC vs TOVX Comparison
Compare PFBC & TOVX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | PFBC | TOVX |
|---|---|---|
| Founded | 1991 | 2001 |
| Country | United States | United States |
| Employees | 324 | N/A |
| Industry | Major Banks | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.1B | 6.4M |
| IPO Year | N/A | 2012 |
Fundamental Metrics
Financial Performance| Metric | PFBC | TOVX |
|---|---|---|
| Price | $87.69 | $0.19 |
| Analyst Decision | Hold | Hold |
| Analyst Count | 3 | 1 |
| Target Price | ★ $102.67 | N/A |
| AVG Volume (30 Days) | 89.1K | ★ 6.5M |
| Earning Date | 04-24-2026 | 03-12-2026 |
| Dividend Yield | ★ 3.60% | N/A |
| EPS Growth | N/A | ★ 89.07 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $2.94 | N/A |
| Revenue Next Year | $8.31 | N/A |
| P/E Ratio | $8.85 | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $73.08 | $0.16 |
| 52 Week High | $103.05 | $1.50 |
Technical Indicators
Market Signals| Indicator | PFBC | TOVX |
|---|---|---|
| Relative Strength Index (RSI) | 43.84 | 50.89 |
| Support Level | $84.63 | $0.17 |
| Resistance Level | $93.52 | $0.26 |
| Average True Range (ATR) | 2.15 | 0.01 |
| MACD | -0.04 | 0.00 |
| Stochastic Oscillator | 36.43 | 37.45 |
Price Performance
Historical ComparisonAbout PFBC Preferred Bank
Preferred Bank is a commercial bank located in California. Its products and services are divided into Personal Banking, Business Banking, and Commercial Banking, which include Checking accounts, Savings accounts, CDs, Loans and Credit, Electronic banking, and Treasury Management. It provides personalized deposit services, real estate finance, commercial loans, and trade finance credit facilities to small and mid-sized businesses and their owners, entrepreneurs, real estate developers and investors, professionals, and high-net-worth individuals.
About TOVX Theriva Biologics Inc.
Theriva Biologics Inc is a clinical-stage pharmaceutical company developing a novel oncolytic adenovirus (OV) platform to address devastating cancers with high unmet needs. It is a clinical-stage program VCN-01, designed to break down the tumor stroma, and its preclinical-stage program VCN-11 leverages its proprietary Albumin Shield Technology to protect systemically administered oncolytic viruses from the host immune system.